TMO 써모피셔 사이언티픽 · Thermo Fisher Scientific Inc

52주 신고가. 다만 90일 내부자 매도 $6,156만.

종가$694.02
시가총액$2,551억
업종헬스케어
다음 실적 발표2026-10-21
PER36.6배
매출 성장(최근 4분기)+7.2%
영업이익률18%
애널리스트 순상향률+14%
목표가 상승여력+1.8%
공매도 거래 비중42%
유명 투자자 보유4곳
1년 수익률+28%

다른 이름: 써모피셔

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, co

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목